ENOV logo

Enovis Corporation Stock Price

NYSE:ENOV Community·US$1.7b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

ENOV Share Price Performance

US$27.96
-19.92 (-41.60%)
US$33.00
Fair Value
US$27.96
-19.92 (-41.60%)
15.3% undervalued intrinsic discount
US$33.00
Fair Value
Price US$27.96
AnalystLowTarget US$33.00
AnalystConsensusTarget US$49.67

ENOV Community Narratives

AnalystLowTarget·
Fair Value US$33 15.3% undervalued intrinsic discount

Delayed Launches And Integration Risks Will Restrain Orthopedics Despite Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$49.67 43.7% undervalued intrinsic discount

Next Generation Orthopedic Technology Will Transform Global Care

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Trending Discussion

Updated Narratives

ENOV logo

Next Generation Orthopedic Technology Will Transform Global Care

Fair Value: US$49.67 43.7% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ENOV logo

Delayed Launches And Integration Risks Will Restrain Orthopedics Despite Demand

Fair Value: US$33 15.3% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks
3 Rewards

Enovis Corporation Key Details

US$2.2b

Revenue

US$880.5m

Cost of Revenue

US$1.4b

Gross Profit

US$2.7b

Other Expenses

-US$1.4b

Earnings

Last Reported Earnings
Oct 03, 2025
Next Reporting Earnings
n/a
-23.91
60.57%
-61.23%
67.2%
View Full Analysis

About ENOV

Founded
1995
Employees
7367
CEO
Damien McDonald
WebsiteView website
www.enovis.com

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Recent ENOV News & Updates

Enovis Corporation (NYSE:ENOV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Nov 09
Enovis Corporation (NYSE:ENOV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Recent updates

No updates